Miprogen Vaginal gel
Product Info
Prescription required | Yes |
Marketer | Bharat Serums & Vaccines Ltd |
Active Ingredient | Progesterone (8% w/w) |
Storage | Store below 30°C |
Chemical Class | Progesterone Derivative |
Habit Forming | No |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | Natural Progesterone |
User Rating | 4.1 |
User Reviews | 684 |
FAQ
Miprogen Vaginal gel Reviews
You should use Miprogen Vaginal as your doctor has advised. Do not use more or less than you have been advised and do not use it for longer than recommended. You may be asked to continue taking this medicine for a period after it is confirmed that you are pregnant.
The most common side effects include headache, feeling very tired, stomach cramps, pain or swelling in your abdomen and feeling sick. You may also feel bloated, less interested in sex and get pain or discharge in your vagina. Your doctor or nurse may be able to help you reduce or prevent side effects if they bother you or do not go away. Very occasionally people get a severe allergic reaction which needs urgent medical attention. Using this medicine may increase your risk of blood clots or breast cancer.
Miprogen Vaginal may not suit everybody, and you should tell your doctor if you have, or have had, breast cancer, unusual bleeding in the vagina or liver disease. You may be monitored more carefully if you have liver, kidney or heart problems or have diabetes or asthma. Let your doctor know your medical history to be safe. Check with your doctor about all other medicines which may affect, or be affected by, this medicine. You will probably have several tests both before and during treatment to check your womb. This medicine can alter your thinking or reactions and you may feel very tired so be careful if you drive or need to be alert. In general, alcohol is not recommended while taking this medicine.
How Miprogen Vaginal gel Works
How to Use Miprogen Vaginal gel
Benefits of Miprogen Vaginal gel
- In Hormone replacement therapy: Hormone Placement Therapy (HRT) is a treatment to relieve symptoms of menopause such as hot flushes, night sweats, mood swings, vaginal dryness, and reduced sex drive. Since menopause can last for several years, this treatment can make a big improvement to your daily life and mood. Progesterone is one of two important hormones (the other is estrogen) used in this treatment. Vaginal tablets and gels are an easy way to deliver hormones but may not treat all the symptoms. You should use this medicine as it is prescribed, and for as long as it is prescribed by your doctor.
- In Female infertility: Miprogen Vaginal contains progesterone, a female hormone that is important in the regulation of ovulation and menstruation. It is used to cause menstrual periods in women who have not reached menopause but are not having periods due to a lack of natural progesterone in the body. Progesterone helps to prepare the uterus for pregnancy by causing the uterus lining (endometrium) to thicken. This increases the chance of a successful pregnancy. You should use the medicine as prescribed for it to be effective. You may be asked to continue with this treatment for a period after becoming pregnant.
Uses of Miprogen Vaginal gel
- Female infertility
- Hormone replacement therapy
Miprogen Vaginal gel Side Effects
Safety Tips
Quick Tips
- You may get a brownish or white discharge during this time. It is not unusual, but talk to your doctor if it bothers you.
- If you become pregnant, it can be used for another 10 to 12 weeks until your progesterone levels are high enough.
- Do not use tampons or other vaginal products for at least 6 hours before and after using Miprogen Vaginal.
- Miprogen Vaginal helps increase your chances of getting pregnant. It prepares the lining of your uterus to receive and nourish a fertilized egg.
- It also helps regulate menstrual cycle in women who do not have a regular period due to a decrease in the hormone progesterone.
- It exposes your body to less hormone invasion compared to pills or injections thereby preventing various gastric side effects.
References
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198.
- Progesterone. Poland Street, London: Besins Healthcare (UK) Ltd.; 2012 [revised 29 Jun. 2017].
- Progesteroene. Feltham, Middlesex: Merck; 2013 [revised Mar. 2015].
- Draft Guidance on Progesterone, February 2022
- Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 706-707.
- Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1180-85.
- Central Drugs Standard Control Organisation (CDSCO).
- Progesterone [Prescribing Information]. Pittsburgh, PA: Nutritional Specialties, Inc.; 2023.